DNase I(50U/μl)
Cat. No. DNI-B52H3
DNase I Informations sur la molécule
Molecule Name
Deoxyribonuclease 1
Alias de la molécule
DNase I,Deoxyribonuclease-1,Deoxyribonuclease I
Drug Development Progress
Nombre de médicaments cliniques1
Nombre de médicaments commercialisés1
Phase de R&D la plus avancéeApproved
Alias de la cible
EC:3.1.21.1，Deoxyribonuclease I，Dornase alfa，DNase I， Lysosomal，DNase I，DNL1，DNASE1，Deoxyribonuclease 1，DRNI，Human Urine Deoxyribonuclease I，Deoxyribonuclease-1，EC 3.1.21.1
Contexte de la molécule
Serum endocuclease secreted into body fluids by a wide variety of exocrine and endocrine organs. Expressed by non-hematopoietic tissues and preferentially cleaves protein-free DNA (By similarity). Among other functions, seems to be involved in cell death by apoptosis. Binds specifically to G-actin and blocks actin polymerization. Together with DNASE1L3, plays a key role in degrading neutrophil extracellular traps (NETs) (By similarity). NETs are mainly composed of DNA fibers and are released by neutrophils to bind pathogens during inflammation (By similarity).
DNase I Liste de produits
Species
- Bovine（1）
Tag
- His Tag（1）
Host
- HEK293（1）
Conjugate
- Unconjugated（1）
Grade
- RUO（1）
Low Endotoxin
- No（1）
| Molecule | Cat. No. | Product Name | Espèce | Host | Structure | Purity | Activity | Size&Price | Add to Cart |
|---|---|---|---|---|---|---|---|---|---|
| DNase I | DNase I(50U/μl) |  Bovine | HEK293 | $48.00 1000U |   |
You Have Viewed 1-1 Of 1 Results
Asset Licensing Opportunity
Resources
Informations sur les médicaments cliniques
| Nom anglais | Code de recherche | Phase de R&D | Entreprise | Indication | Essai clinique |
|---|---|---|---|---|---|
| repurposed deoxyribonuclease I (Human Microbiology Institute) | Clinical | Alzheimer Disease | Details |
Informations sur les médicaments commercialisés
| Nom anglais | Code de recherche | Phase de R&D | Entreprise | Plus ancien nom de marque | Pays d'approbation le plus ancien | Indication la plus ancienne | Société d'approbation la plus ancienne | Date d'approbation la plus ancienne | Indication | Essai clinique |
|---|---|---|---|---|---|---|---|---|---|---|
| Chorionic Gonadotropin | LDI-200 | Approved | Angiogene Pharmaceuticals | Prostatic Neoplasms; Leukemia, Myeloid, Acute; Infertility, Female; Hypogonadism; Cryptorchidism | Details |
Customer Reviews